Treatment of the mouse neuroblastoma cell line, N1E-115, with the HDAC inhibitor, valproic acid (VPA), has been shown to specifically upregulate Gadd45a protein expression and induce neurite outgrowth from these cells via activation of the MAP3K, MEKK4 [10]. This evidence concerns the gene MAP3K4 and neuroblastoma.